Tracking Ovulation With PCOS: Why OPKs Mislead and What Works Instead

Why Do Ovulation Tests Mislead in PCOS?

Seventy-five percent of anovulatory PCOS patients have a pooled LH level above the normal range, and 94% have an elevated LH-to-FSH ratio, according to a study of 61 women with PCOS compared against 24 cycling controls who had blood sampled every 10 minutes for 8–12 hours. That single fact explains most of what goes wrong with an over-the-counter ovulation predictor kit (OPK) in PCOS.

An OPK is built on a simple assumption: LH sits low most of the month, then spikes sharply 24–36 hours before ovulation, and the test detects that spike crossing a fixed threshold. In PCOS, the baseline is often already close to — or above — that threshold before any ovulatory surge happens. A small, ordinary fluctuation in an already-elevated hormone can trip the test, which is why so many people with PCOS report a test line that looks “always positive,” or positive several times in one cycle. The kit is not broken. It is measuring exactly what it says it measures — it was just never calibrated for a baseline this high. The same elevated LH-to-FSH ratio that shows up on a diagnostic blood panel is the reason the at-home version of the same hormone misbehaves too.

Note: in May 2026, PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS, by a global consensus of more than 50 organisations. Same condition, same hormone pattern — only the label changed. This article uses PCOS, since that is still the term most readers search.

If Your Pattern Is Lean, Expect an Even Higher Baseline

Pooled LH correlated inversely with body mass index in the same study — a relationship strong enough (R = -0.59) that leaner PCOS patients tended to run the highest LH levels of anyone in the sample, while higher-BMI patients ran comparatively lower. That is a specific, practical warning for lean PCOS: the phenotype most often assumed to be “milder” because BMI and insulin markers look normal is, on this particular hormone, often the one furthest from baseline — and therefore the group most likely to see an OPK behave erratically. Insulin-resistant phenotypes are not exempt from elevated LH either; they simply tend to run somewhat lower than the lean pattern on this specific measurement, not lower than a cycling woman without PCOS.

Do I Ovulate With PCOS at All?

Nearly 15% of the women with PCOS in the same gonadotropin study had a normal pooled LH level, because they had ovulated spontaneously within the prior 21 days — a reminder that “PCOS” does not mean zero ovulation, even in a clinically selected research population. Anovulation in PCOS is usually intermittent rather than absolute: some months produce a mature egg and a real hormonal shift, others do not, and the ratio between the two varies by phenotype, weight, and how the individual case has been managed.

That intermittency is also the direct answer to “can you get pregnant with irregular periods.” Irregular periods are usually a symptom of irregular ovulation, not proof that ovulation never happens — the two get conflated constantly, and they are not the same claim. A 45-day cycle can still be an ovulatory cycle, just a later one. The practical question is not “do I ever ovulate” but “which of my cycles are the ovulatory ones,” and that is a tracking problem, not a yes/no diagnosis. For what that means for actual chances of conceiving over a full year, rather than one cycle at a time, the real cumulative numbers are covered here.

What Actually Confirms Ovulation in PCOS

Three methods work in PCOS where a standard OPK does not, and each one confirms something slightly different, on a different timeline.

A random serum progesterone level of 5 ng/mL or higher confirmed ovulation with 89.6% sensitivity and 98.4% specificity in a study of 102 women tracked across 260 cycles using daily urine testing, cervical mucus observation, and ultrasound as the reference standard. That single blood draw is one of the most reliable single data points available outside a fertility clinic — the catch is entirely about timing it correctly, which matters more in PCOS because the ovulation window itself is less predictable to begin with.

What a PCOS BBT Chart Actually Looks Like

A biphasic BBT chart — lower readings for the first half of the cycle, then a sustained rise of roughly 0.5–1°F after ovulation — is the sign that ovulation has happened, and a luteal phase of 10–14 days after that rise is consistent with a normal ovulatory cycle. In PCOS, three things make that chart harder to read than the tidy examples in a fertility app: the pre-ovulatory phase can run long and irregular, so the rise arrives on cycle day 25 as easily as day 14; anovulatory cycles produce a flat, monophasic chart with no clear rise at all; and a genuinely erratic sleep or illness pattern can produce noise that looks like a temperature shift but isn’t.

None of that makes BBT useless — it makes it a confirmation tool rather than a prediction tool. Charting daily for a full cycle or two, without expecting a clean result on the first attempt, is what turns a noisy chart into a usable one. A rise that holds for at least three days and lines up with any other sign of ovulation is a real signal; a single elevated reading is not.

Consistency of measurement matters more than the specific thermometer. Taking a temperature at a wildly different time each morning, or after getting up to move around first, adds noise that can look exactly like a real shift. A basal reading means the first reading of the day, taken before sitting up, at roughly the same time — small details, but they are the difference between a chart that shows a genuine pattern and one that looks random regardless of what the ovaries are actually doing.

Putting a Realistic Approach Together

The combination that shows up across the fertility literature — and that the 2023 international PCOS guideline supports as reasonable self-monitoring alongside clinical care — is BBT charting for a baseline pattern, plus a well-timed serum progesterone test once a temperature shift or other sign suggests ovulation may have occurred. Ultrasound follicle tracking is the guideline’s recommended step when active fertility treatment is underway and precise timing matters for medication or intercourse timing, since it is the only method on this list that watches the follicle directly rather than inferring it from a downstream hormone.

None of this is a fixed sequence everyone should follow in the same order — it is a set of options with different costs, different accuracy, and different levels of clinical support behind them, worth bringing to a clinician who can say which combination fits a specific cycle pattern. Anyone actively trying to conceive and using a fertility medication should ask specifically about how clomiphene and letrozole affect this tracking picture, since an induced cycle behaves differently from a spontaneous one.

This is one piece of a larger picture. Tracking correctly answers “did this cycle produce an egg”; it does not by itself answer “what are my odds this year” or “which treatment fits my case” — both of which are covered elsewhere in the site’s fertility coverage. Getting the tracking right is what makes the rest of that picture accurate instead of guesswork, which is why it is worth getting right before anything else.

When This Needs a Doctor Sooner Rather Than Later

Common questions